Tumor Necrosis Factor Alpha and Apoptosis in Helicobacter pylori Related Progressive Gastric Damage: A Possible Mechanism of Immune System Involvement in Epithelial Turnover Regulation
暂无分享,去创建一个
S. Marangi | M. Barone | R. Cuomo | A. Francavilla | A. Di Leo | E. Ierardi | C. Panella | R. Francavilla | O. Burattini | A. Panarese | M. Margiotta
[1] M. Karin,et al. Inhibition of JNK activation through NF-κB target genes , 2001, Nature.
[2] Francesca Zazzeroni,et al. Induction of gadd45β by NF-κB downregulates pro-apoptotic JNK signalling , 2001, Nature.
[3] S. Marangi,et al. Helicobacter heilmannii gastritis: a histological and immunohistochemical trait. , 2001, Journal of clinical pathology.
[4] S. Marangi,et al. Pattern of apoptosis in Crohn's disease: a singular aspect? , 2001, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[5] H. Fujiki,et al. Helicobacter pylori membrane protein 1: a new carcinogenic factor of Helicobacter pylori. , 2001, Cancer research.
[6] K. Nave,et al. Differential expression of apoptotic markers in jimpy and in Plp overexpressors: evidence for different apoptotic pathways , 2001, Journal of neurocytology.
[7] F. Russo,et al. CIRCULATING CYTOKINES AND GASTRIN LEVELS IN ASYMPTOMATIC SUBJECTS INFECTED BY HELICOBACTER PYLORI (H. PYLORI) , 2001, Immunopharmacology and immunotoxicology.
[8] S. Dandekar,et al. A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques. , 2000, Gastroenterology.
[9] E. Furth,et al. Altered gastric epithelial cell kinetics in Helicobacter pylori‐associated intestinal metaplasia: Implications for gastric carcinogenesis , 2000, International journal of cancer.
[10] F. Russo,et al. Helicobacter pylori infection and host cell responses. , 1999, Immunopharmacology and immunotoxicology.
[11] T. Jang,et al. Adherence of Helicobacter pylori to areas of type II intestinal metaplasia in Korean gastric mucosa. , 1999, Yonsei medical journal.
[12] G. de Rosa,et al. Effect of Helicobacter pyloriinfection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis , 1999, Gut.
[13] G. Gabay,et al. Expression of bcl-2 in Autoimmune and Helicobacter pylori-Associated Atrophic Gastritis , 1999, Digestive Diseases and Sciences.
[14] A. Slomiany,et al. Induction of caspase‐3 and nitric oxide synthase‐2 during gastric mucosal inflammatory reaction to Helicobacter pylori lipopolysaccharide , 1998, Biochemistry and molecular biology international.
[15] P. Galle,et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. , 1998, The Journal of clinical investigation.
[16] A. Gasbarrini,et al. Importace of changes in epithelial cell turnover during Helicobacter pylori infection in gastric carcinogenesis , 1998, Gut.
[17] P. Galle,et al. H. Pylori-induced gastric epithelial apoptosis is mediated by the CD95 (Fas) receptor and ligand system , 1998 .
[18] H. Yeger,et al. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. , 1997, The American journal of pathology.
[19] A. Pisani,et al. Effect of Helicobacter pylori eradication on gastric epithelial proliferation. Relationship with ras oncogene p21 expression. , 1997, Italian journal of gastroenterology and hepatology.
[20] S. Ito,et al. Combined effect of 5-fluorouracil and recombinant tumor necrosis factor against human gastric carcinoma cell lines. , 1996, Anticancer research.
[21] A. Francavilla,et al. Proliferative activity of gastric epithelium in progressive stages ofHelicobacter pylori infection , 1996, Digestive Diseases and Sciences.
[22] H. Sasano,et al. IN SITU ANALYSIS OF TISSUE DYNAMICS AND p53 EXPRESSION IN HUMAN GASTRIC MUCOSA , 1996, The Journal of pathology.
[23] A. Di Leo,et al. Successful eradicating treatment of Helicobacter pylori in patients with chronic gastritis: gastric levels of cytokines, epidermal growth factor and polyamines before and after therapy. , 1996, Immunopharmacology and immunotoxicology.
[24] X. Fan,et al. Helicobacter pylori increases proliferation of gastric epithelial cells. , 1996, Gut.
[25] G. Daar,et al. Serum levels of interleukin-1, interleukin-6 and tumour necrosis factor-alpha in patients with gastric carcinoma. , 1995, Cancer letters.
[26] G. Lauwers,et al. Immunohistochemical evidence of aberrant bcl‐2 protein expression in gastric epithelial dysplasia , 1994, Cancer.
[27] R. Pounder,et al. Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation , 1994, Alimentary pharmacology & therapeutics.
[28] M. Rugge,et al. p53 alteration in gastric precancerous lesions. , 1994, The American journal of pathology.
[29] R. Riddell,et al. Reduce, reuse, and recycle: Shedding light on shedding cells , 1993, Gastroenterology.
[30] D. Ahnen,et al. Proliferating cell nuclear antigen expression in normal, preneoplastic, and neoplastic colonic epithelium of the rat. , 1992, Gastroenterology.
[31] A. Price. The Sydney System: Histological division , 1991, Journal of gastroenterology and hepatology.
[32] M. Saegusa,et al. Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia , 2005, Journal of Cancer Research and Clinical Oncology.
[33] J. M. Kim,et al. Apoptosis of human gastric epithelial cells via caspase-3 activation in response to Helicobacter pylori infection: possible involvement of neutrophils through tumor necrosis factor alpha and soluble Fas ligands. , 2000, Scandinavian journal of gastroenterology.
[34] P. Rutgeerts,et al. Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis. , 1999, Gastroenterology.